Instruction for use: Vicks Active Sinex

ATX code R01AA05 Oxymetazoline

Pharmacotherapeutic group:

Decongestant agent - alpha-agonists [alpha agonists]

Decongestant agent - alpha-agonists [decongestant]

The nosological classification (ICD-10)

J00 Acute nasopharyngitis [runny nose]

Viral rhinitis, Inflammation of the nasopharynx, Inflammatory diseases of the nose, purulent rhinitis, Nasal congestion, Nasal congestion with colds and flu, The difficulty of nasal breathing, The difficulty of nasal breathing for colds, Difficulty in nasal breathing, Difficulty in nasal breathing in colds, nasal, hypersecretion, cold, ARI with rhinitis phenomena, coryza, Acute rhinitis of various origins, Acute rhinitis with thick purulent mucous exudate, Acute nasopharyngitis, Swelling of the mucosa of the nasopharynx, Rhinitis, rhinorrhea, Infectious-inflammatory diseases of ENT organs, heavy cold, rhinopharyngitis, nasopharyngitis

J01 Acute sinusitis

Inflammation of the sinuses, Inflammatory diseases of the paranasal sinuses, Purulent inflammation of the paranasal sinuses, Infectious-inflammatory diseases of ENT organs, Infection of the sinuses, Combined sinusitis, Exacerbation of sinusitis, Acute inflammation of the paranasal sinuses, Acute bacterial sinusitis, Acute sinusitis in adults, Subacute sinusitis, acute Sinusitis, sinusitis

J06 Acute upper respiratory infections of multiple and unspecified

Frequent colds viral diseases, Infections of the upper respiratory tract, Acute respiratory disease influenza character, for colds Pain, Acute colds,Cold, respiratory infection,Seasonal colds, Pain in infectious and inflammatory diseases of the upper respiratory tract, Bacterial infections of the upper respiratory tract, Bacterial respiratory infections, Viral disease of the respiratory tract, Viral respiratory tract infections, Inflammatory disease of the upper respiratory tract, Inflammation of the upper respiratory tract disease, Inflammation of the upper respiratory tract illness with difficult sputum, Inflammatory airway disease, Secondary infections with colds, Shortness of sputum in acute and chronic respiratory diseases, Upper respiratory tract infection, Infections of the upper respiratory tract, Respiratory Tract Infections, Infections of the respiratory tract and lungs, Infectious-inflammatory diseases of the upper respiratory tract, Infectious-inflammatory diseases of the upper respiratory tract and ENT-organs, Infectious-inflammatory diseases of the upper respiratory tract in children and adults, Infectious-inflammatory diseases of the upper respiratory tract, Infectious inflammation of the airways,respiratory infection, Qatar upper respiratory tract, Catarrh of the upper respiratory tract, Catarrhal disease of the upper respiratory tract, Catarrhal symptoms of the upper respiratory tract, Coughing with a cold, SARS, ARI, ARI with rhinitis phenomena, Acute respiratory infection, Acute infectious and inflammatory disease of the upper respiratory tract, Acute respiratory disease, Sore throat or nose, Respiratory viral infections, Respiratory diseases, Respiratory infections, Recurrent respiratory infections, Secondary infection with influenza, cold in the chest, Feverish condition with flu

J30 Vasomotor and allergic rhinitis

Allergic rinopatiya, Allergic rhinosinusopathy, Allergic respiratory diseases, Allergic rhinitis, nasal allergy, Seasonal Allergic Rhinitis, Vasomotor rhinitis, Long-allergic rhinitis, Perennial allergic rhinitis, Perennial allergic rhinitis, Year-round or seasonal allergic rhinitis, Year-round allergic rhinitis nature, Rhinitis allergic vasomotor, Exacerbation of pollen allergy in the form of Syndrome rinokonyunktivalnogo, Acute allergic rhinitis, Edema of the nasal mucosa, Edema of the nasal mucosa, Swelling of the mucosa of the nasal cavity, Swelling of the nasal mucosa, Swelling of the nasal mucosa, pollen disease, Permanent allergic rhinitis, rhinoconjunctivitis, rhinosinusitis,rhinosinusopathy, Seasonal allergic rhinitis, Seasonal Allergic Rhinitis, Haymarket rhinitis, Chronic allergic rhinitis, Allergic respiratory diseases

J31 Chronic rhinitis, nasopharyngitis and pharyngitis

Allergic rhinosinusopathy, Inflammation of the nasal mucosa, Infectious-inflammatory diseases of upper respiratory tract, Catarrh nasopharyngeal area, Year-round rhinitis, Özen, Sore throat or nose, Rhinitis hyperplastic, chronic Rhinitis, Faringoezofagit, Chronic bacterial rhinitis

J32 Chronic sinusitis

Allergic rhinosinusopathy, purulent sinusitis, Catarrh nasopharyngeal area, Catarrh of the sinuses, Exacerbation of sinusitis, chronic Sinusitis

Composition

Nasal Spray 100 ml

active substance:

oxymetazoline hydrochloride 0.05 g

excipients: sorbitol (70% aqueous solution) - 5 g; Sodium citrate dihydrate - 0.875 g; tyloxapol - 0.7 g; Chlorhexidine digluconate (20% solution) - 0.27 g; anhydrous citric acid - 0.2 g; Aloe Vera - 0.1 g; benzalkonium chloride (50% solution) - 0.04 g; levomenthol - 0,015 g; acesulfame potassium - 0,015 g; cineole - 0.013 g; L-carvone - 0.01 g; disodium edetate - 0.01 g; sodium hydroxide (0.1 M solution) - up to pH 5.4; distilled water - 100 ml

Description

Spray: white or almost white gel suspension with a characteristic odor.

Pharmacological Properties of Vicks Active Sinex

Pharmachologic effect
antikongestat

Dosage and Administration

Intranasal.

Adults and children over 10 years - 1-2 injections in each nostril maximum 2-3 times daily.

Children from 6 to 10 years - 1 injection in each nostril maximum 2-3 times daily.

Duration of treatment is not recommended to use the drug for more than 7 days. Frequent or prolonged use of the drug sense of difficulty in nasal breathing may reappear or worsen. should stop treatment and seek medical attention if these symptoms. When injected not throw back his head back and spray into the prone position.

Overdose

Symptoms: When large overdose or accidental ingestion possible nausea, vomiting, cyanosis, fever, tachycardia, arrhythmias, increased blood pressure, shortness of breath, mental disorders, CNS depression (drowsiness, decrease in body temperature, bradycardia, decreased blood pressure, respiration and coma stop).

Treatment: symptomatic; Accidental ingestion - gastric lavage, activated charcoal. Vasopressor drugs are contraindicated.

release Form

Nasal Spray 0.05%. In 15 ml amber glass vials; 1 fl. in a cardboard bundle.

Storage conditions of Vicks Active Sinex

The temperature is not higher than 25 ° C.

Keep out of the reach of children.
Shelf life of Vicks Active Sinex

3 years.

Do not use beyond the expiration date printed on the package.

Available without prescription.